These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85. Hepatitis C and kidney disease: A narrative review. Barsoum RS; William EA; Khalil SS J Adv Res; 2017 Mar; 8(2):113-130. PubMed ID: 28149647 [TBL] [Abstract][Full Text] [Related]
86. Antiviral treatment prioritization in HCV-infected patients with extrahepatic manifestations - An Egyptian perspective. El-Fishawy H; Saadi G; Hassaballa M; Hussein M; Doss W; Ragab G; Barsoum R J Adv Res; 2016 May; 7(3):391-402. PubMed ID: 27222744 [TBL] [Abstract][Full Text] [Related]
87. Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia. Aulitzky WE; Peschel C; Desprès D; Aman J; Trautman P; Tilg H; Rudolf G; Hüttmann H; Obermeier J; Herold M Ann Hematol; 1993 Nov; 67(5):205-11. PubMed ID: 7694661 [TBL] [Abstract][Full Text] [Related]
89. Tolerance of one-month intranasal interferon. Scott GM; Onwubalili JK; Robinson JA; Doré C; Secher DS; Cantell K J Med Virol; 1985 Oct; 17(2):99-106. PubMed ID: 2997387 [TBL] [Abstract][Full Text] [Related]
90. Interferons as cytokines regulating leukocyte functions in vivo. Virelizier JL Ann Inst Pasteur Immunol (1985); 1985; 136D(1):73-7. PubMed ID: 2415041 [No Abstract] [Full Text] [Related]
91. Safety evaluation of biotechnology products. Zbinden G Drug Saf; 1990; 5 Suppl 1():58-64. PubMed ID: 2182064 [TBL] [Abstract][Full Text] [Related]
92. Pharmacokinetics of recombinant interferon alpha-C. Merimsky O; Rubinstein M; Fischer D; Danon A; Chaitchik S Cancer Chemother Pharmacol; 1991; 27(5):406-8. PubMed ID: 1999003 [TBL] [Abstract][Full Text] [Related]
93. [Interferons--its method of administration and adverse effect related to pharmacokinetics ]. Furue H Gan To Kagaku Ryoho; 1984 Feb; 11(2):186-93. PubMed ID: 6582804 [TBL] [Abstract][Full Text] [Related]
94. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon. Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433 [TBL] [Abstract][Full Text] [Related]
95. Interferon: pharmacokinetics and toxicity. Scott GM Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):91-107. PubMed ID: 6183699 [TBL] [Abstract][Full Text] [Related]
96. Pharmacokinetics and side effects of interferon in man. Merigan TC Tex Rep Biol Med; 1977; 35():541-7. PubMed ID: 358475 [No Abstract] [Full Text] [Related]
97. Toxicity of interferon. Scott GM; Secher DS; Flowers D; Bate J; Cantell K; Tyrrell DA Br Med J (Clin Res Ed); 1981 Apr; 282(6273):1345-8. PubMed ID: 6165428 [TBL] [Abstract][Full Text] [Related]